Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy

Nature Genetics
A D IrvineW H McLean

Abstract

The intermediate filament cytoskeleton of corneal epithelial cells is composed of cornea-specific keratins K3 and K12 (refs 1,2). Meesmann's corneal dystrophy (MCD) is an autosomal dominant disorder causing fragility of the anterior corneal epithelium, where K3 and K12 are specifically expressed. We postulated that dominant-negative mutations in these keratins might be the cause of MCD. K3 was mapped to the type-II keratin gene cluster on 12q; and K12 to the type-I keratin cluster on 17q using radiation hybrids. We obtained linkage to the K12 locus in Meesmann's original German kindred (Zmax = 7.53; theta = 0) and we also showed that the phenotype segregated with either the K12 or the K3 locus in two Northern Irish pedigrees. Heterozygous missense mutations in K3 (E509K) and in K12 (V143L; R135T) completely co-segregated with MCD in the families and were not found in 100 normal unrelated chromosomes. All mutations occur in the highly conserved keratin helix boundary motifs, where dominant mutations in other keratins have been found to severely compromise cytoskeletal function, leading to keratinocyte fragility phenotypes. Our results demonstrate for the first time the molecular basis of Meesmann's corneal dystrophy.

References

May 1, 1977·American Journal of Ophthalmology·B S FineF D Slaughter
Dec 1, 1990·Cell Differentiation and Development : the Official Journal of the International Society of Developmental Biologists·C Chaloin-DufauD Dhouailly
Jan 1, 1987·Journal of Molecular Evolution·E M KlingeM Blumenberg
Jan 1, 1987·Differentiation; Research in Biological Diversity·M RodriguesT T Sun
Nov 1, 1993·Current Eye Research·C Y LiuW W Kao
Feb 1, 1995·Current Opinion in Cell Biology·W H McLean, E B Lane
Mar 1, 1995·Nature Genetics·W H McLeanC Higgins
Mar 1, 1995·Human Molecular Genetics·E HéonE M Stone
Jan 1, 1994·Nature Genetics·E M StoneL M Streb
Apr 1, 1996·American Journal of Ophthalmology·K W SmallR Yee
Dec 1, 1995·Human Molecular Genetics·N M TomaS S Bhattacharya
Oct 1, 1996·Human Molecular Genetics·A M ShearmanJ S Weiss
Dec 1, 1996·Experimental Dermatology·L D Corden, W H McLean
Mar 1, 1997·Nature Genetics·F L MunierD F Schorderet

❮ Previous
Next ❯

Citations

Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D M ToivolaJ E Eriksson
May 8, 2008·Histochemistry and Cell Biology·Roland MollLutz Langbein
Feb 28, 2009·Human Genetics·Meral Julia Arin
Jul 29, 2008·Japanese Journal of Ophthalmology·Takahiko SetoAtsushi Kanai
Aug 19, 2007·Cell Biochemistry and Biophysics·Madhu BudamaguntaJohn Voss
Feb 15, 2005·Clinics in Dermatology·Alan D Irvine
Mar 5, 2004·Survey of Ophthalmology·Ian M MacDonaldMaria A Musarella
Dec 28, 1999·American Journal of Ophthalmology·G K Klintworth
Aug 15, 2002·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Rong LiMichael Brenner
Oct 8, 1999·Journal of Dermatological Science·K TakahashiY Miyachi
Mar 4, 1998·Current Opinion in Cell Biology·M K Houseweart, D W Cleveland
Jul 27, 2001·Progress in Retinal and Eye Research·S KinoshitaK Okubo
Jun 14, 2002·Progress in Retinal and Eye Research·Susanne Pitz, Roland Moll
Aug 8, 1998·Progress in Retinal and Eye Research·T Kivelä, M Uusitalo
Jul 18, 2002·The Journal of Biological Chemistry·John F HessPaul G FitzGerald
Sep 6, 2011·Human Molecular Genetics·W H Irwin McLean, C B Tara Moore
Sep 27, 2006·Cornea·Shiro AmanoSeiichi Yokoo
Apr 8, 2009·Cornea·Jayne S WeissGordon K Klintworth
Feb 24, 2004·The British Journal of Ophthalmology·J S RamalhoM C Seabra
Jun 12, 1999·The British Journal of Ophthalmology·L TongD Atherton
Apr 27, 2000·The British Journal of Ophthalmology·L D CordenW H McLean
Jun 27, 2002·The British Journal of Ophthalmology·A D IrvineW H I McLean
Dec 13, 2012·Investigative Ophthalmology & Visual Science·Edwin H A AllenC B Tara Moore
Jul 10, 2009·The Journal of Clinical Investigation·M Bishr Omary
Feb 25, 2009·Orphanet Journal of Rare Diseases·Gordon K Klintworth
Apr 12, 2003·American Journal of Clinical Dermatology·Frances Smith
Oct 7, 2014·The Ocular Surface·R LakshminarayananJodhbir S Mehta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.